NCT04820023 2025-06-06Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI TreatmentBridge Biotherapeutics, Inc.Phase 1/2 Terminated45 enrolled 19 charts
NCT04515979 2024-12-09Vactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) SubjectsMedPacto, Inc.Phase 2 Terminated11 enrolled
NCT02101684 2018-03-05Greko IIGrupo EspaƱol de Tumores HuƩrfanos e InfrecuentesPhase 2 Terminated10 enrolled
NCT01254136 2012-01-25Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerIncyte CorporationPhase 1/2 Terminated20 enrolled